CapEx at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xenon Pharmaceuticals's capex?
- Xenon Pharmaceuticals (XENE) reported capex of $133K in Q1 2026.
- How has Xenon Pharmaceuticals's capex changed year-over-year?
- Xenon Pharmaceuticals's capex increased by 209.3% year-over-year, from $43K to $133K.
- What is the long-term trend for Xenon Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's capex has grown at a -21.0% compound annual growth rate (CAGR), from $2.05M to $799K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.